Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?

被引:170
作者
Corre, Jill [1 ,2 ]
Hebraud, Benjamin [3 ]
Bourin, Philippe [4 ]
机构
[1] Inst Natl Sante & Rech Med INSERM, U1037, Toulouse, France
[2] Univ Hosp Purpan, Hematol Lab, Toulouse, France
[3] Univ Hosp Purpan, Dept Hematol, Toulouse, France
[4] CSA21, F-31100 Toulouse, France
关键词
Cancer; Clinical translation; Drug target; Malignancy; MACROPHAGE INHIBITORY CYTOKINE-1; TGF-BETA SUPERFAMILY; ACTIVATED GENE NAG-1; MESENCHYMAL STEM-CELLS; PROSTATE-CANCER CELLS; MULTIPLE-MYELOMA; PANCREATIC ADENOCARCINOMA; RISK STRATIFICATION; HEART-FAILURE; HUMAN BREAST;
D O I
10.5966/sctm.2013-0055
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Growth differentiation factor 15 (GDF15) is a divergent member of the transforming growth factor 13 family discovered in a broad range of cells, as indicated by the diversity of its nomenclature. However, the only tissue that expresses a high amount of GDF15 in the physiologic state is placenta. GDF15 is easily detected in blood, and its concentration varies with age. In fact, increased blood concentration of GDF15 is associated with numerous pathological conditions. However, the biological significance underlying these observations is far from clear. GDF15 could have a positive or negative role depending on the state of cells or their environment. Furthermore, study of its biology is hampered by lack of knowledge of its receptor and thus the signaling pathways that drive its action. GDF15 seems to be an integrative signal in pathologic conditions, giving information on severity of disease. Its effectiveness in classifying patients to modulate treatment remains to be shown. Development of therapeutic interventions with GDF15 or anti-GDF15 agents remains difficult until we uncover the mechanism that drives its activity.
引用
收藏
页码:946 / 952
页数:7
相关论文
共 72 条
[1]   Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 [J].
Albertoni, M ;
Shaw, PH ;
Nozaki, M ;
Godard, S ;
Tenan, M ;
Hamou, MF ;
Fairlie, DW ;
Breit, SN ;
Paralkar, VM ;
de Tribolet, N ;
Van Meir, EG ;
Hegi, ME .
ONCOGENE, 2002, 21 (27) :4212-4219
[2]   Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia [J].
Baek, Seung Joon ;
Okazaki, Ryuji ;
Lee, Seong-Ho ;
Martinez, Jeanelle ;
Kim, Jong-Sik ;
Yamaguchi, Kiyoshi ;
Mishina, Yuji ;
Martin, David W. ;
Shoieb, Ahmed ;
Mcentee, Michael F. ;
Eling, Thomas E. .
GASTROENTEROLOGY, 2006, 131 (05) :1553-1560
[3]   Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein [J].
Baek, SJ ;
Kim, JS ;
Moore, SM ;
Lee, SH ;
Martinez, J ;
Eling, TE .
MOLECULAR PHARMACOLOGY, 2005, 67 (02) :356-364
[4]   Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 [J].
Baek, SJ ;
Wilson, LC ;
Eling, TE .
CARCINOGENESIS, 2002, 23 (03) :425-434
[5]   Common cancer biomarkers [J].
Basil, CF ;
Zhao, YD ;
Zavaglia, K ;
Jin, P ;
Panelli, MC ;
Voiculescu, S ;
Mandruzzato, S ;
Lee, HM ;
Seliger, B ;
Freedman, RS ;
Taylor, PR ;
Hu, N ;
Zanovello, P ;
Marincola, FM ;
Wang, E .
CANCER RESEARCH, 2006, 66 (06) :2953-2961
[6]   The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome [J].
Bauskin, AR ;
Brown, DA ;
Junankar, S ;
Rasiah, KK ;
Eggleton, S ;
Hunter, M ;
Liu, T ;
Smith, D ;
Kuffner, T ;
Pankhurst, GJ ;
Johnen, H ;
Russell, PJ ;
Barret, W ;
Stricker, PD ;
Grygiel, JJ ;
Kench, JG ;
Henshall, SM ;
Sutherland, RL ;
Breit, SN .
CANCER RESEARCH, 2005, 65 (06) :2330-2336
[7]   Growth Differentiation Factor-15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin-6-Dependent Inflammatory Response to Vascular Injury [J].
Bonaterra, Gabriel A. ;
Zuegel, Stefanie ;
Thogersen, Joel ;
Walter, Sabrina A. ;
Haberkorn, Uwe ;
Strelau, Jens ;
Kinscherf, Ralf .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (06) :e002550
[8]   MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily [J].
Bootcov, MR ;
Bauskin, AR ;
Valenzuela, SM ;
Moore, AG ;
Bansal, M ;
He, XY ;
Zhang, HP ;
Donnellan, M ;
Mahler, S ;
Pryor, K ;
Walsh, BJ ;
Nicholson, RC ;
Fairlie, WD ;
Por, SB ;
Robbins, JM ;
Breit, SN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11514-11519
[9]   Macrophage Inhibitory Cytokine-1 Is Overexpressed in Malignant Melanoma and Is Associated with Tumorigenicity [J].
Boyle, Glen M. ;
Pedley, Julie ;
Martyn, Adam C. ;
Banducci, Kelly J. ;
Strutton, Geoffrey M. ;
Brown, David A. ;
Breit, Samuel N. ;
Parsons, Peter G. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (02) :383-391
[10]   Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease [J].
Breit, Samuel N. ;
Carrero, Juan J. ;
Tsai, Vicky Wang-Wei ;
Yagoutifam, Nasreen ;
Luo, Wei ;
Kuffner, Tamara ;
Bauskin, Asne R. ;
Wu, Liyun ;
Jiang, Lele ;
Barany, Peter ;
Heimburger, Olof ;
Murikami, Mary-Ann ;
Apple, Fred S. ;
Marquis, Christopher P. ;
Macia, Laurence ;
Lin, Shu ;
Sainsbury, Amanda ;
Herzog, Herbert ;
Law, Matthew ;
Stenvinkel, Peter ;
Brown, David A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) :70-75